Letronat 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Natco Pharma Ltd
  4. Letronat 2.5 mg Tablet

Letronat 2.5 mg Tablet

Letronat 2.5 mg Tablet contains letrozole 2.5 mg, an aromatase inhibitor. It is primarily used to treat hormone-receptor-positive breast cancer in postmenopausal women. The tablet is taken orally as prescribed by the doctor.

BUY NOW

Category

Letrozole lowers estrogen production in the body, which can help slow the growth of hormone-dependent breast cancer cells. It may be prescribed after menopause as part of breast cancer treatment. Treatment duration and dosing depend on the patient’s condition and medical response. Medical monitoring may be recommended during long-term therapy.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route Oral
Pack Size 10 Tablets
Manufacturer Natco Pharma Ltd

Product Also Known As

Letronat 2.5 Tablet, Letronat 2.5 mg Tablet, Letronat 2.5mg Tablet, Letrozole 2.5 mg Tablet, Letrozole 2.5mg Tablet, Letrozole Oral Tablet, Letrozole Anticancer Tablet